Thomas Flaten
Stock Analyst at Lake Street
(2.76)
# 1,423
Out of 5,127 analysts
35
Total ratings
35.14%
Success rate
2.22%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSTL Castle Biosciences | Maintains: Buy | $35 → $52 | $32.37 | +60.64% | 7 | Jan 12, 2026 | |
| PTHS Pelthos Therapeutics | Initiates: Buy | $50 | $22.51 | +122.17% | 1 | Dec 3, 2025 | |
| CNTB Connect Biopharma Holdings | Initiates: Buy | $9 | $2.68 | +235.82% | 1 | Dec 1, 2025 | |
| MDXH MDxHealth | Maintains: Buy | $7 → $9 | $3.62 | +148.62% | 1 | Nov 13, 2025 | |
| EVAX Evaxion | Maintains: Buy | $6 → $11 | $3.44 | +220.23% | 3 | Oct 20, 2025 | |
| HROW Harrow | Maintains: Buy | $42 → $70 | $47.71 | +46.72% | 1 | Sep 29, 2025 | |
| DERM Journey Medical | Maintains: Buy | $9 → $13 | $8.10 | +60.49% | 2 | Aug 13, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Buy | $8 | $4.08 | +96.08% | 1 | Jul 28, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $11 → $14 | $8.36 | +67.46% | 2 | Jul 18, 2025 | |
| AYTU Aytu BioPharma | Initiates: Buy | $8 | $2.31 | +246.32% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $10.40 | +284.62% | 1 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $3.86 | +107.25% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $8.62 | +4.41% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $45 | $11.68 | +285.27% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $11 | $4.36 | +152.29% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $22.65 | +10.38% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $0.44 | +326,504.67% | 2 | Nov 17, 2022 |
Castle Biosciences
Jan 12, 2026
Maintains: Buy
Price Target: $35 → $52
Current: $32.37
Upside: +60.64%
Pelthos Therapeutics
Dec 3, 2025
Initiates: Buy
Price Target: $50
Current: $22.51
Upside: +122.17%
Connect Biopharma Holdings
Dec 1, 2025
Initiates: Buy
Price Target: $9
Current: $2.68
Upside: +235.82%
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $3.62
Upside: +148.62%
Evaxion
Oct 20, 2025
Maintains: Buy
Price Target: $6 → $11
Current: $3.44
Upside: +220.23%
Harrow
Sep 29, 2025
Maintains: Buy
Price Target: $42 → $70
Current: $47.71
Upside: +46.72%
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $13
Current: $8.10
Upside: +60.49%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $4.08
Upside: +96.08%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $8.36
Upside: +67.46%
Aytu BioPharma
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.31
Upside: +246.32%
May 14, 2025
Maintains: Buy
Price Target: $60 → $40
Current: $10.40
Upside: +284.62%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $3.86
Upside: +107.25%
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $8.62
Upside: +4.41%
Mar 12, 2024
Maintains: Buy
Price Target: $60 → $45
Current: $11.68
Upside: +285.27%
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $4.36
Upside: +152.29%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $22.65
Upside: +10.38%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $0.44
Upside: +326,504.67%